Arrowstreet Capital LP recently announced the acquisition of new stake in Exela Technologies Inc. (NASDAQ:XELA). This fresh investment now brings its stake to 1.07% valued currently at $0.81 million. In addition, Goldman Sachs & Co. LLC (Private.. raised its holdings by 0.65 million to 0.81 million shares.
With over 1.42 million Exela Technologies Inc. (XELA) shares trading Friday and a closing price of $0.45 on the day, the dollar volume was approximately $0.64 million. The shares have shown a negative weekly performance of -0.04% and its price on 08/28/20 lost nearly -0.11%. Currently, there are 147.51M common shares owned by the public and among those 60.70M shares have been available to trade.
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 1 analysts who have offered their price forecasts for XELA have a consensus price objective of $1.55. The analysts have set the share’s price value over the next 12 months at a high of $1.55 and a low of $1.55 should the stock experience a downside. Incidentally, analysts’ outlook for the Exela Technologies Inc. stock is 2.00 for the next 12 months. But an upside of 70.97% will see the stock hit the forecast high price target while mean target price for the stock is $1.55.
Insiders at the company have transacted a total of 25 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 19 of these insider trades were purchases, accounting for 4,370,811 shares. Insider sales of the common stock occurred on 6 occasions, with total insider shares sold totaling 105,906 shares.
The top 3 mutual fund holders in Exela Technologies Inc. are Vanguard Total Stock Market Index, Vanguard Extended Market Index Fu, and Invesco FTSE RAFI US 1500 Small M. Vanguard Total Stock Market Index owns 1.21 million shares of the company’s stock, all valued at over $0.62 million. Invesco FTSE RAFI US 1500 Small M sold 1786.0 shares to bring its total holdings to over 0.44 million shares at a value of $0.22 million. Invesco FTSE RAFI US 1500 Small M now owns shares totaling to 0.30% of the shares outstanding.
Shares of Exela Technologies Inc. (NASDAQ: XELA) opened at $0.45, unchanged from a prior closing price of $0.45. However, the script later closed the day at $0.45, down -0.11%. The company’s stock has a 5-day price change of -0.04% and 37.18% over the past three months. XELA shares are trading 10.77% year to date (YTD), with the 12-month market performance down to -60.39% lower. It has a 12-month low price of $0.09 and touched a high of $1.63 over the same period. Currently, 1.42 million shares have been traded, compared to an average intraday trading volume of 13.05 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -10.31%, -11.45%, and 24.44% respectively.
Institutional ownership of Exela Technologies Inc. (NASDAQ: XELA) shares accounts for 62.50% of the company’s 147.51M shares outstanding. Mutual fund holders own 2.67%, while other institutional holders and individual stakeholders account for 29.05% and 15.66% respectively.
It has a market capitalization of $66.64M and a beta (3y monthly) value of 1.86. The earnings-per-share (ttm) stands at -$3.39. Price movements for the stock have been influenced by the stock’s volatility, which stands at 7.12% over the week and 8.79% over the month.
Analysts forecast that Exela Technologies Inc. (XELA) will achieve an EPS of $0 for the current quarter, -$0.21 for the next quarter and -$0.48 for 2021. The lowest estimate earnings-per-share for the quarter is $0 while analysts give the company a high EPS estimate of $0. Comparatively, EPS for the current quarter was -$0.23 a year ago.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 1 brokerage firm advisors rate Exela Technologies Inc. (XELA) as a “Moderate Buy” at a consensus score of 2.00. Specifically, 1 Wall Street analysts polled rate the stock as a buy, while 0 of the 1 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the XELA, a number of firms have released research notes about the stock. Morgan Stanley stated their Equal-Weight rating for the stock in a research note on January 16, 2019, with the firm’s price target at. Morgan Stanley coverage for the Exela Technologies Inc. (XELA) stock in a research note released on October 22, 2018 offered a Overweight rating with a price target of $9.